Examining FDA's Prescription Drug User Fee program :  hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017. 
 Examining Food and Drug Administration's prescription drug user fee program 

 - v, 107 pages :  illustrations ;  24 cm 
<br/><br/> Shipping list no .: 2018-0094-M.  "Serial No. 115-18."  CRDP Program record. 
<br/><br/>Includes bibliographical references. 
<br/><br/><br/>Microfiche. <br/>[Washington, D.C.] : <br/>U.S. Government Printing Office, <br/>[2018] <br/>2 microfiches : negative. 
<br/><br/><label>Subjects--Corporate Names: </label><br/>United States. Prescription Drug User Fee Act of 1992. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>User charges--Law and legislation--United States.<br/>Drugs--Law and legislation--United States.<br/>Prescription pricing--Law and legislation--United States.<br/>Generic drugs--Prices--United States.<br/>Drug accessibility--Government policy--United States.<br/>Drug approval--United States.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Legislative hearings.
<br/><br/><label>LC Class. No.: </label>KF27  / .E553 2017 
<br/><br/><label>GPO Item No.: </label>1019-B-01 (MF) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.C 73/8:115-18 
<br/><br/><label>Report. No.: </label>Serial no. 115-18 (United States. Congress. House. Committee on Energy and Commerce)